Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04966663
Title Using ctDNA to Determine Therapies for Lung Cancer (ctDNA Lung RCT)
Recruitment Recruiting
Phase Phase II
Variant Requirements No
Sponsors University Health Network, Toronto

lung non-small cell carcinoma


Carboplatin + Nivolumab + Pemetrexed Disodium

Cisplatin + Gemcitabine + Nivolumab

Cisplatin + Nivolumab + Pemetrexed Disodium

Carboplatin + Gemcitabine + Nivolumab

Age Groups: senior | adult
Covered Countries CAN

No variant requirements are available.